Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience

A. Ergonul (Izmir, Turkey)

Source: International Congress 2017 – General thoracic surgery
Session: General thoracic surgery
Session type: Thematic Poster
Number: 2458
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ergonul (Izmir, Turkey). Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience. 2458

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of surgery and of radiotherapy in malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020


Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience.
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020


Surgery and multimodality treatment for malignant pleural mesothelioma
Source: Eur Respir Mon; 2009: 44: 407–418
Year: 2009

Thoracoscopic palliative treatment of malignant pleural effusions
Source: Annual Congress 2011 - A little bit of everything: interventional pneumology
Year: 2011

Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions
Source: Eur Respir J 2004; 24: 263-266
Year: 2004



Surgical problems with the malignant pleural space
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



Is prophylactic radiotherapy at intervention site always neccessary in malign pleural mesothelioma?
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

Malignant pleural disease in primary lung cancer
Source: Eur Respir Mon; 2009: 44: 318–335
Year: 2009

The role of video-assisted thoracoscopy in the diagnosis of malignant pleural mesothelioma
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011

Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Possibilities of reconstruction during pleuropneumonectomy with resection of pericardium and diaphragm in patients with malignant pleural mesothelioma
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

The effectiveness of concomitant endobronchial treatment and video assisted thoracic surgery pleurodesis in lung cancer cases with pleural effusion
Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS)
Year: 2017

Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003